From left to right: Dr. Thomas Page, vice president, engineering & asset development, FUJIFILM Diosynth Biotechnologies, Texas Eric Dul, senior director vaccines, FUJIFILM Diosynth Biotechnologies ...
FUJIFILM Diosynth Biotechnologies and the Texas A&M University System Center for Innovation in Advanced Development and Manufacturing have announced that production has begun on two different COVID-19 ...
The Texas A&M University System and Fujifilm Diosynth Biotechnologies Texas announced last week a partnership working to train the workforce that is mass-producing two COVID-19 vaccine candidates for ...
Japan's Fujifilm has been building up its drug manufacturing assets as one way to move away from its roots in photography. It already has biologics capabilities, but now is buying vaccine specialist ...
Texas had offered up an incentives package that — including free land, tax abatements and training — would have been worth more than $300 million. Amid the coronavirus pandemic, the slew of state, ...
Texas is adding another building block for its hopes of becoming a biotech hub. Fujifilm Diosynth broke ground on its $300 million medical manufacturing facility expansion, the Houston Chronicle ...
FUJIFILM Diosynth Biotechnologies plans to expand its single-use manufacturing campus in College Station, TX, through the addition of a new cGMP production facility that will double the company’s ...
NORTH KINGSTOWN, R.I., April 29, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Electronic Materials, U.S.A., Inc. (FUJIFILM Electronic Materials) today announced that it earned a Texas Instruments (TI) 2023 ...
Fujifilm will spend $28 million to further increase biopharmaceutical capacity at its contract manufacturing plants in Texas and England. In College Station, Texas, the Japanese company will build a ...
College Station, Texas, Oct. 25, 2022 (GLOBE NEWSWIRE) -- FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization for biologics, vaccines, and advanced ...
COLLEGE STATION, Texas (KBTX) - FUJIFILM Diosynth Biotechnologies announced Monday that it has started mass manufacturing two COVID-19 vaccine candidates. FUJIFILM Texas Chief Operating Officer Gerald ...